HIV-1 Epidemic Control - Insights from Test-and-Treat Trials.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Impact of male circumcision on risk of HIV infection in men in a changing epidemic context - systematic review and meta-analysis.Journal of the International AIDS Society · 2020
   Pooled it
2. A community mobilisation intervention to improve engagement in HIV testing, linkage to care, and retention in care in South Africa: a cluster-randomised controlled trial.The lancet. HIV · 2022
   Trial
3. The impact of financial incentives on HIV incidence among adolescent girls and young women in Eswatini: Sitakhela Likusasa, a cluster randomised trial.BMJ global health · 2022
   Trial
4. Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial - BCPP/Ya Tsie trial.eLife · 2022
   Trial
5. Effect of door-to-door distribution of HIV self-testing kits on HIV testing and antiretroviral therapy initiation: a cluster randomised trial in Malawi.BMJ global health · 2021
   Trial
6. Effect of community-led delivery of HIV self-testing on HIV testing and antiretroviral therapy initiation in Malawi: A cluster-randomised trial.PLoS medicine · 2021
   Trial
7. How 'place' matters for addressing the HIV epidemic: evidence from the HPTN 071 (PopART) cluster-randomised controlled trial in Zambia and South Africa.Trials · 2021
   Trial
8. Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya.PloS one · 2021
   Trial
9. Unpacking sources of transmission in HIV prevention trials with deep-sequence pathogen data.Nature communications · 2026
   Article
10. Expanding single-venue services to better engage young people who inject drugs: insights from India.Harm reduction journal · 2024
    Review
11. Immunologic, virologic and drug resistance outcomes in an HIV-infected prospective cohort on treatment in South Africa.PloS one · 2024
    Observational
12. Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART).Open forum infectious diseases · 2022
    Article
13. Cost-effectiveness of implementing HIV and HIV/syphilis dual testing among key populations in Viet Nam: a modelling analysis.BMJ open · 2022
    Article
14. Understanding mechanisms of impact from community-led delivery of HIV self-testing: Mediation analysis of a cluster-randomised trial in Malawi.PLOS global public health · 2022
    Article
15. Young and invisible: a qualitative study of service engagement by people who inject drugs in India.BMJ open · 2021
    Article
16. Effective Human Immunodeficiency Virus Molecular Surveillance Requires Identification of Incident Cases of Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
17. Law, criminalisation and HIV in the world: have countries that criminalise achieved more or less successful pandemic response?BMJ global health · 2021
    Review
18. Large age shifts in HIV-1 incidence patterns in KwaZulu-Natal, South Africa.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
19. Implementing 'universal' access to antiretroviral treatment in South Africa: a scoping review on research priorities.Health policy and planning · 2021
    Article
20. Phylogenetic Cluster Analysis: Persons With Undiagnosed Infection Drive Human Immunodeficiency Virus Transmission in a Population With High Levels of Virologic Suppression.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article

Corrections and comments

• Comment on
  Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).2019
• Comment on
  HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa.2019
• Comment on
  Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana.2019

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as